New Zealand markets open in 4 hours 11 minutes

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
22.28-0.12 (-0.54%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 7.24B
Enterprise value 6.81B
Trailing P/E 38.83
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.30
Price/book (mrq)4.64
Enterprise value/revenue 7.35
Enterprise value/EBITDA 29.01

Trading information

Stock price history

Beta (5Y monthly) 0.44
52-week change 3-0.49%
S&P500 52-week change 323.76%
52-week high 330.49
52-week low 321.27
50-day moving average 323.83
200-day moving average 325.89

Share statistics

Avg vol (3-month) 31.29M
Avg vol (10-day) 31.41M
Shares outstanding 5323.09M
Implied shares outstanding 6323.09M
Float 8115.93M
% held by insiders 169.71%
% held by institutions 18.35%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.24
Forward annual dividend yield 41.07%
Trailing annual dividend rate 30.19
Trailing annual dividend yield 30.83%
5-year average dividend yield 4N/A
Payout ratio 422.67%
Dividend date 3N/A
Ex-dividend date 406 Jun 2024
Last split factor 21.3:1
Last split date 306 Jun 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 21.83%
Operating margin (ttm)23.79%

Management effectiveness

Return on assets (ttm)7.48%
Return on equity (ttm)13.70%

Income statement

Revenue (ttm)925.89M
Revenue per share (ttm)2.89
Quarterly revenue growth (yoy)29.60%
Gross profit (ttm)N/A
EBITDA 249.76M
Net income avi to common (ttm)202.09M
Diluted EPS (ttm)0.58
Quarterly earnings growth (yoy)20.50%

Balance sheet

Total cash (mrq)493.36M
Total cash per share (mrq)1.53
Total debt (mrq)63.7M
Total debt/equity (mrq)4.08%
Current ratio (mrq)2.77
Book value per share (mrq)4.83

Cash flow statement

Operating cash flow (ttm)200.84M
Levered free cash flow (ttm)-22.6M